Suppr超能文献

早期目标导向性肾脏替代疗法治疗严重肺炎相关性急性肾损伤。

Early goal-directed renal replacement therapy in severe pneumonia associated acute kidney injury.

机构信息

Department of Nephrology, Zhongshan Hospital, Fudan University, Shanghai Medical Center of Kidney, Shanghai Key Laboratory of Kidney and Blood Purification, Shanghai, China.

Department of Nephrology, Xiamen Branch, Zhongshan Hospital, Fudan University, Nephrology Clinical Quality Control Center of Xiamen, Xiamen, Fujian, China.

出版信息

Ren Fail. 2024 Dec;46(2):2392844. doi: 10.1080/0886022X.2024.2392844. Epub 2024 Sep 4.

Abstract

INTRODUCTION

Severe pneumonia is a crucial issue in the development of acute kidney injury (AKI). This study evaluated the efficacy of early goal-directed renal replacement therapy (GDRRT) for the treatment of severe pneumonia-associated AKI.

METHODS

In this real-world retrospective cohort study, we recruited 180 patients with severe pneumonia who were hospitalized and received GDRRT in a third-class general hospital in East China between January 1, 2017, and December 31, 2021. Clinical data on baseline characteristics, biochemical indicators, and renal replacement therapy were collected. Patients were divided into Early and Late RRT groups according to fluid status, inflammation progression, and pulmonary radiology. We investigated in-hospital all-cause mortality (primary endpoint) and renal recovery (secondary endpoint) between the two groups.

RESULTS

Among the 154 recruited patients, 80 and 74 were in the early and late RRT groups, respectively. There were no significant differences in the demographic characteristics between the two groups. The duration of admission to RRT initiation was significantly shorter in Early RRT group [2.5(1.0, 8.7) d vs. 5.0(1.5,13.5) d,  = 0.027]. At RRT initiation, the patients in the Early RRT group displayed a lower percentage of fluid overload, lower doses of vasoactive agents, higher CRP levels, and higher rates of radiographic progression than those in the Late RRT group. The all-cause in-hospital mortality was significantly lower in the Early RRT group than in Late group (52.5% vs. 86.5%,  < 0.001). Patients in the Early RRT group displayed a significantly higher proportion of complete renal recovery at discharge (40.0% vs. 8.1%,  < 0.001).

CONCLUSION

This study clarified that early GDRRT for the treatment of severe pneumonia-associated AKI based on fluid status and inflammation progression, was associated with reduced hospital mortality and better recovery of renal function. Our preliminary study suggests that early initiation of RRT may be an effective approach for severe pneumonia-associated AKI.

摘要

简介

严重肺炎是急性肾损伤(AKI)发展过程中的一个关键问题。本研究评估了早期目标导向性肾脏替代治疗(GDRRT)治疗严重肺炎相关性 AKI 的疗效。

方法

本真实世界回顾性队列研究纳入了 2017 年 1 月 1 日至 2021 年 12 月 31 日期间在华东地区一家三级综合医院住院并接受 GDRRT 的 180 例严重肺炎患者。收集了基线特征、生化指标和肾脏替代治疗的临床数据。根据液体状态、炎症进展和肺部影像学将患者分为早期和晚期 RRT 组。我们调查了两组之间的院内全因死亡率(主要终点)和肾功能恢复(次要终点)。

结果

在招募的 154 例患者中,80 例和 74 例分别进入早期和晚期 RRT 组。两组之间的人口统计学特征没有显著差异。早期 RRT 组的 RRT 起始至入院时间明显缩短[2.5(1.0,8.7)d 比 5.0(1.5,13.5)d,=0.027]。在 RRT 起始时,早期 RRT 组的液体超负荷比例、血管活性药物剂量、CRP 水平和影像学进展率均低于晚期 RRT 组。早期 RRT 组的院内全因死亡率明显低于晚期 RRT 组(52.5%比 86.5%,<0.001)。早期 RRT 组出院时完全肾功能恢复的比例明显高于晚期 RRT 组(40.0%比 8.1%,<0.001)。

结论

本研究表明,基于液体状态和炎症进展的严重肺炎相关性 AKI 的早期 GDRRT 治疗与降低住院死亡率和更好的肾功能恢复相关。我们的初步研究表明,早期开始 RRT 可能是治疗严重肺炎相关性 AKI 的一种有效方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5366/11376310/cf668412a46d/IRNF_A_2392844_F0001_B.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验